Surgical screening protocol for craniocervical instability secondary to ehlers-danlos syndrome and other connective tissue disorders: analysis of a 347 patient case series

针对埃勒斯-当洛斯综合征及其他结缔组织疾病继发的颅颈不稳的手术筛查方案:一项347例患者病例系列分析

阅读:1

Abstract

BACKGROUND: Evaluation of craniocervical instability (CCI) in individuals with connective tissue disorders (CTDs) remains controversial. We present a surgical screening protocol created and implemented at our institution for these individuals. METHODS: We reviewed patients referred to our institution for CCI secondary to CTDs, between May 2018 and April 2022 using our two-stage protocol. Stage 1 included: history, clinical questionnaire, physical examination, non-invasive provocative testing, neuroimaging with morphometric analysis, Karnofsky Performance Scale. Items 1–5 were each scored on a 0 to 2 scale. Individuals with a KPS ≤ 70 and an aggregate score ≥ 6 were recommended for Stage 2, which included additional neuroimaging, psychiatric evaluation, and a trial of intraoperative craniocervical traction (ICT) with clinical and morphometric scores. Individuals meeting criteria in both stages were considered surgical candidates. Postoperative outcomes were assessed. RESULTS: Of the 347 individuals entering Stage 1, 190 progressed through Stage 2. Following advanced evaluation, 115 patients met full surgical qualification criteria, with 95 proceeding to craniocervical fusion (CCF) and reporting an 86.4% satisfaction rate on the North American Spine Society (NASS) satisfaction index. Twelve additional patients with borderline morphometric scores were offered surgery due to marked clinical improvement during ICT; however, this Subgroup demonstrated a lower NASS satisfaction rate (70%). CONCLUSIONS: We present a two-stage surgical evaluation protocol for CCI in patients with CTDs. ICT served as a critical diagnostic tool, clarifying the biomechanical contribution of CCI to symptomatology and aiding in the identification of appropriate surgical candidates. Further multicenter studies are warranted for validation. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s10143-026-04195-z.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。